|
|
TAN 23 HM 0329
|
Pumpinox 20mg
|
Esomeprazole Magnesium Trihydrate 20 mg
|
Pharma International Company
|
Registered/Compliant
|
Details →
|
|
|
TAN 23 HM 0330
|
Pumpinox 40mg
|
Esomeprazole Magnesium Trihydrate 40 mg
|
Pharma International Company
|
Registered/Compliant
|
Details →
|
|
|
TAN 00,4279 D07X GAL
|
Pyloocain ointment
|
Betamethasone Valerate 0.5 mg/g,Lidocaine Hydrochloride 25 mg/g,Phenylephrine Hydrochloride 1 mg/g
|
Galentic Pharma (India) Private Limited
|
Registered/Compliant
|
Details →
|
|
|
TAN 06,369 D08A BRO
|
Pyodine
|
Povidone Iodine 1 %w/w
|
Brookes Pharmaceuticals Laboratories (Pakistan) Limited
|
Registered/Compliant
|
Details →
|
|
|
TAN 06,369 D08A BRO
|
Pyodine Solution
|
Povidone Iodine 1 %w/v
|
Brookes Pharmaceuticals Laboratories (Pakistan) Limited
|
Registered/Compliant
|
Details →
|
|
|
TZ10H077
|
Pyodine Sugical Scrub
|
D.I Water MU/0.5 mL,Fenopan Co-434 (RHODAPEX) gm/ 5mL,Povidone Iodine 7.5 g/100 mL,Sodium Hydroxide gm/ 5mL,Surfadone LP-300 gm/ 5mL
|
Brookes Pharmaceuticals Laboratories (Pakistan) Limited
|
Registered/Compliant
|
Details →
|
|
|
TZ10H077
|
Pyodine Surgical scrub
|
D.I Water MU/0.5 mL,Fenopan Co-434 (RHODAPEX) gm/ 5mL,Povidone Iodine 7.5 g/100 mL,Sodium Hydroxide gm/ 5mL,Surfadone LP-300 gm/ 5mL
|
Brookes Pharma Pvt Limited
|
Registered/Compliant
|
Details →
|
|
|
TZ 17 H 0055
|
Pyramax
|
Artesunate 20 mg,Pyronaridine Tetraphosphate 60 mg
|
Shin Poong Pharmaceutical Company Limited
|
Registered/Compliant
|
Details →
|
|
|
TZ 17 H 0056
|
Pyramax
|
Artesunate 60 mg,Pyronaridine Tetraphosphate 180 mg
|
Shin Poong Pharmaceutical Company Limited
|
Registered/Compliant
|
Details →
|
|
|
TAN 00,1410 S01A FDC
|
Pyricort Ear/Eye Drops
|
Benzalkonium chloride IU/ml,Dexamethasone Sodium Phosphate equivalent to Dexamethasone Phosphate 0.1 % w/v,Disodium Edetate IU/ml,Disodium phosphate dodecahydrate IU/ml,Gentamycin Sulphate equivalent to Gemtamicin 0.3 % w/v,Sodium Dihydrogen Phosphate Dihydrate IU/ml
|
FDC Limited
|
Registered/Compliant
|
Details →
|
|
|
TAN 00,4405 P01B MED
|
Pyrimethamine + Sulfadoxine
|
Pyrimethamine 25 mg,Sulfadoxine 500 mg
|
Medopharm
|
Registered/Compliant
|
Details →
|
|
|
TZ 20 H 0220
|
Pyrolate
|
Glycopyrrolate 0.2 mg/ml
|
Brookes Pharma Private Limited
|
Registered/Compliant
|
Details →
|
|
|
TAN 22 HM 0525
|
Q-PANTOOP
|
Pantoprazole Sodium
|
-
|
Registered/Compliant
|
Details →
|
|
|
TAN 23 HM 0576
|
Q-TIB
|
Isoniazid 300 mg,Pyridoxine 25 mg,Sulfamethoxazole 800 mg,Trimethoprim 160 mg/6 mL
|
Quality Chemical Industries Limited (QCIL)
|
Registered/Compliant
|
Details →
|
|
|
TAN 25 AD 0220
|
QPOL-ANTISEPTIC LIQUID
|
Isopropyl Alcohol (IPA) 40 %v/v,chloroxylenol 4.8 % w/v,pine oil 5 mg/ml
|
STERLING SURFACTANTS LIMITED
|
Registered/Compliant
|
Details →
|
|
|
TZ11H153
|
QUINALIN Syrup
|
Quinine Bisulphate equivalent to Quinine 100 mg/5 ml
|
SHELYS PHARMACEUTICALS LTD
|
Registered/Compliant
|
Details →
|
|
|
TAN 21 VM 0501
|
QUININTAS
|
Enrofloxacin
|
-
|
Registered/Compliant
|
Details →
|
|
|
TAN 21 HM 0478
|
QUITIDE 200
|
Calcium Hydrogen Phosphate Dihydrate 20.00 mg/6 mL,Hypromellose (6cps) 11.719 mg/6 mL,Isopropyl Alcohol q.s ml/ml,Lactose Monohydrate 41.333 mg/6 mL,Macrogol 400 1.172 mg/6 mL,Magnesium Stearate 8.667 mg/6 mL,Microcrystalline cellulose (PH101) 115.723 mg/6 mL,Opacode S-1-17823 Black q.s mg/ mL,Povidone (K-30) 18.000 mg/6 mL,Quetiapine fumarate 200 mg/6 mL,Rifampicin 22.533 mg/6 mL,Silica colloidal anhydrous 2.500 mg/6 mL,Sodium Starch Glycolate Type A 36.000 mg/6 mL,Talc 5.000 mg/6 mL,Titanium dioxide 5.859 mg/6 mL
|
Aurobindo Pharma Limited, Unit-III
|
Registered/Compliant
|
Details →
|
|
|
TAN 21 HM 0477
|
QUITIDE 300
|
Calcium Hydrogen Phosphate Dihydrate 30.000 mg/6 mL,Hypromellose 6cps 17.578 mg/6 mL,Isopropyl Alcohol q.s ml/ml,Lactose Monohydrate 62.000 mg/6 mL,Macrogol 400 1.758 mg/6 mL,Magnesium Stearate 13.000 mg/6 mL,Microcrystalline cellulose (PH101) 173.584 mg/6 mL,Opacode S-1-17823 Black q.s ml/ml,Povidone (K-30) 27.000 mg/6 mL,Quetiapine (as Quetiapine fumarate) 300 mg/6 mL,Rifampicin 33.800 mg/6 mL,Silica colloidal anhydrous 3.750 mg/6 mL,Sodium Starch Glycolate Type A 54.000 mg/6 mL,Talc 7.500 mg/6 mL,Titanium dioxide 8.789 mg/6 mL
|
Aurobindo Pharma Limited, Unit-III
|
Registered/Compliant
|
Details →
|
|
|
TAN 26 HM 0471
|
Qlaira
|
Dienogest (Light yellow tablets) 3 mg,Dienogest (medium red tablets) 2 mg,Dienogest, micronized (for Phase 2 of the FPP) 2.000 mg,Dienogest, micronized (for Phase 3 of the FPP) 3.000 mg,Estradiol valerate (Dark red tablets) 1 mg,Estradiol valerate (Light yellow tablets) 2 mg,Estradiol valerate (dark yellow tablets) 3 mg,Estradiol valerate (medium red tablets) 2 mg,Estradiol valerate, micronized (for Phase 1 of the FPP) 3.000 mg,Estradiol valerate, micronized (for Phase 2 of the FPP) 2.000 mg,Estradiol valerate, micronized (for Phase 3 of the FPP) 2.000 mg,Estradiol valerate, micronized (for Phase 4 of the FPP) 1.000 mg,Ferric oxide, red (for Phase 2 of the FPP) 0.03906 mg,Ferric oxide, red (for Phase 4 of the FPP) 0.3651 mg,Ferric oxide, yellow (for Phase 1 of the FPP) 0.2920 mg,Ferric oxide, yellow (for Phase 3 of the FPP) 0.03906 mg,Hypromellose 5 cP (for Phases 1, 2, 3 and 4 of the FPP) 1.5168 mg,Hypromellose 5 cP (for Placebo of the FPP) 1.0112 mg,Lactose monohydrate (for Phase 1 of the FPP) 48.360 mg,Lac
|
Bayer AG, Berlin
|
Registered/Compliant
|
Details →
|